Literature DB >> 2199891

Cicatricial pemphigoid and erythema multiforme.

B J Mondino1.   

Abstract

Cicatricial pemphigoid (CP) and erythema multiforme (EM) are bullous diseases that involve the skin and mucous membranes including the conjunctiva. Of all the bullous diseases, CP and EM not only involve the conjunctiva most frequently but also cause the most severe conjunctival disease. A chronic, progressive disease, CP is characterized by shrinkage of the conjunctiva, symblepharon, entropion, trichiasis, dry eye, and finally reduced vision from corneal opacification. It is primarily a disease of the elderly that affects more women than men and is characterized by blisters or bullae in a subepithelial location and immunoglobulins and complement bound to the basement membrane zone of skin and mucous membranes including the conjunctiva. Circulating antibodies to the basement membrane zone can be demonstrated occasionally. Treatment includes artificial tears, topical antibiotics, correction of entropion and trichiasis, therapeutic soft contact lenses, and systemic immunosuppressive therapy including corticosteroids. An acute, generally self-limited, inflammatory disorder of the skin and mucous membranes, EM occurs primarily in young, healthy individuals. The most frequent precipitating factors are (1) drugs and (2) infections caused by Mycoplasma pneumoniae and herpes simplex. Conjunctival involvement ranges from a mild catarrhal conjunctivitis which terminates without sequelae to membranous conjunctivitis which may heal leaving scarring, symblepharon, and even ankyloblepharon. Histopathologic findings include subepithelial bullae and perivascular mononuclear cell infiltrates. Patients with EM have circulating immune complexes and immunoreactant deposition in the blood vessel walls of the dermis. After the acute episode has subsided, they may require artificial tears, topical antibiotics, correction of entropion and trichiasis, therapeutic soft contact lenses, tarsorrhaphy, and mucous membrane grafts.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2199891     DOI: 10.1016/s0161-6420(90)32479-x

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  16 in total

Review 1.  Autoimmune bullous diseases: ocular manifestations and management.

Authors:  Caroline Laforest; Shyamala C Huilgol; Robert Casson; Dinesh Selva; Igal Leibovitch
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Long-term results of systemic chemotherapy for ocular cicatricial pemphigoid.

Authors:  C S Foster; R Neumann; J Tauber
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

3.  Eosinophil granule proteins expressed in ocular cicatricial pemphigoid.

Authors:  A Heiligenhaus; J Schaller; S Mauss; S Engelbrecht; J E Dutt; C S Foster; K P Steuhl
Journal:  Br J Ophthalmol       Date:  1998-03       Impact factor: 4.638

Review 4.  Adverse effects of topical antiglaucomatous medications on the conjunctiva.

Authors:  D Broadway; I Grierson; R Hitchings
Journal:  Br J Ophthalmol       Date:  1993-09       Impact factor: 4.638

Review 5.  The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on.

Authors:  J K Dart
Journal:  Eye (Lond)       Date:  2017-01-20       Impact factor: 3.775

6.  Sulphapyridine--a new agent for the treatment of ocular cicatricial pemphigoid.

Authors:  M J Elder; J Leonard; J K Dart
Journal:  Br J Ophthalmol       Date:  1996-06       Impact factor: 4.638

7.  Progression of disease in ocular cicatricial pemphigoid.

Authors:  M J Elder; W Bernauer; J Leonard; J K Dart
Journal:  Br J Ophthalmol       Date:  1996-04       Impact factor: 4.638

8.  Role of cyclophosphamide and high dose steroid in ocular cicatricial pemphigoid.

Authors:  M J Elder; S Lightman; J K Dart
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

Review 9.  Amniotic membrane transplantation as a new therapy for the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Elizabeth Shay; Ahmad Kheirkhah; Lingyi Liang; Hossam Sheha; Darren G Gregory; Scheffer C G Tseng
Journal:  Surv Ophthalmol       Date:  2009-08-21       Impact factor: 6.048

10.  Blood group related antigens in ocular cicatricial pemphigoid.

Authors:  C Creuzot-Garcher; T H Xuan; A M Bron; H Robin; P d'Athis; J Bara
Journal:  Br J Ophthalmol       Date:  2004-10       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.